aluates Reports

$ 0.0

Automative

Global Transdermal Drug Delivery System Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-36I603

Global Transdermal Drug Delivery System Market Insights and Forecast to 2028

BUY CHAPTERS

Global Transdermal Drug Delivery System Market Research Report 2025

Code: QYRE-Auto-36I603

Report

May 2025

Pages:97

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Hisamitsu

Mylan NV

GSK

Novartis

Teve (Actavis)

Johnson & Johnson

Lohmann

TEIKOKU SEIYAKU

Bayer

Lingrui

Sanofi

Qizheng

Endo

Huarun 999

Haw Par

Nichiban

Mentholatum

Laboratoires Genevrier

Transdermal Drug Delivery System Market Size

The global market for Transdermal Drug Delivery System was valued at US$ 19300 million in the year 2024 and is projected to reach a revised size of US$ 45700 million by 2031, growing at a CAGR of 13.3% during the forecast period.

Transdermal Drug Delivery System Market

Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

Global Transdermal Drug Delivery System key players include Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), etc. Global top five manufacturers hold a share over 65%. North America is the largest market, with a share over 40%, followed by Europe and Asia-Pacific, both have a share over 45% percent.

In terms of product, Nitroglycerin is the largest segment, with a share over 25%. And in terms of application, the largest application is OTC, followed by RX.

This report aims to provide a comprehensive presentation of the global market for Transdermal Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Drug Delivery System.

The Transdermal Drug Delivery System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transdermal Drug Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Transdermal Drug Delivery System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Transdermal Drug Delivery System Market Report

Report Metric	Details
Report Name	Transdermal Drug Delivery System Market
Accounted market size in year	US$ 19300 million
Forecasted market size in 2031	US$ 45700 million
CAGR	13.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Fentanyl Nitroglycerin Estradiol Nicotine Other
Segment by Application	OTC Rx
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), Johnson & Johnson, Lohmann, Teikoku Seiyaku, Bayer, Lingrui, Sanofi, Qizheng, Endo, Huarun 999, Haw Par, Nichiban, Mentholatum, Laboratoires Genevrier
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transdermal Drug Delivery System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Transdermal Drug Delivery System Market growing?

Ans: The Transdermal Drug Delivery System Market witnessing a CAGR of 13.3% during the forecast period 2025-2031.

What is the Transdermal Drug Delivery System Market size in 2031?

Ans: The Transdermal Drug Delivery System Market size in 2031 will be US$ 45700 million.

What is the market share of major companies in Transdermal Drug Delivery System Market?

Ans: Global top five manufacturers hold a share over 65%.

What is the Transdermal Drug Delivery System Market share by type?

Ans: In terms of product, Nitroglycerin is the largest segment, with a share over 25%.

Who are the main players in the Transdermal Drug Delivery System Market report?

Ans: The main players in the Transdermal Drug Delivery System Market are Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), Johnson & Johnson, Lohmann, Teikoku Seiyaku, Bayer, Lingrui, Sanofi, Qizheng, Endo, Huarun 999, Haw Par, Nichiban, Mentholatum, Laboratoires Genevrier

What are the Application segmentation covered in the Transdermal Drug Delivery System Market report?

Ans: The Applications covered in the Transdermal Drug Delivery System Market report are OTC, Rx

What are the Type segmentation covered in the Transdermal Drug Delivery System Market report?

Ans: The Types covered in the Transdermal Drug Delivery System Market report are Fentanyl, Nitroglycerin, Estradiol, Nicotine, Other

Recommended Reports

Transdermal Patch Technology

Microneedle Delivery Systems

Advanced Drug Delivery

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Transdermal Drug Delivery System Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Fentanyl

1.2.3 Nitroglycerin

1.2.4 Estradiol

1.2.5 Nicotine

1.2.6 Other

1.3 Market by Application

1.3.1 Global Transdermal Drug Delivery System Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 OTC

1.3.3 Rx

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Transdermal Drug Delivery System Market Perspective (2020-2031)

2.2 Global Transdermal Drug Delivery System Growth Trends by Region

2.2.1 Global Transdermal Drug Delivery System Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Transdermal Drug Delivery System Historic Market Size by Region (2020-2025)

2.2.3 Transdermal Drug Delivery System Forecasted Market Size by Region (2026-2031)

2.3 Transdermal Drug Delivery System Market Dynamics

2.3.1 Transdermal Drug Delivery System Industry Trends

2.3.2 Transdermal Drug Delivery System Market Drivers

2.3.3 Transdermal Drug Delivery System Market Challenges

2.3.4 Transdermal Drug Delivery System Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Transdermal Drug Delivery System Players by Revenue

3.1.1 Global Top Transdermal Drug Delivery System Players by Revenue (2020-2025)

3.1.2 Global Transdermal Drug Delivery System Revenue Market Share by Players (2020-2025)

3.2 Global Transdermal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Transdermal Drug Delivery System Revenue

3.4 Global Transdermal Drug Delivery System Market Concentration Ratio

3.4.1 Global Transdermal Drug Delivery System Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Transdermal Drug Delivery System Revenue in 2024

3.5 Global Key Players of Transdermal Drug Delivery System Head office and Area Served

3.6 Global Key Players of Transdermal Drug Delivery System, Product and Application

3.7 Global Key Players of Transdermal Drug Delivery System, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Transdermal Drug Delivery System Breakdown Data by Type

4.1 Global Transdermal Drug Delivery System Historic Market Size by Type (2020-2025)

4.2 Global Transdermal Drug Delivery System Forecasted Market Size by Type (2026-2031)

5 Transdermal Drug Delivery System Breakdown Data by Application

5.1 Global Transdermal Drug Delivery System Historic Market Size by Application (2020-2025)

5.2 Global Transdermal Drug Delivery System Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Transdermal Drug Delivery System Market Size (2020-2031)

6.2 North America Transdermal Drug Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Transdermal Drug Delivery System Market Size by Country (2020-2025)

6.4 North America Transdermal Drug Delivery System Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Transdermal Drug Delivery System Market Size (2020-2031)

7.2 Europe Transdermal Drug Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Transdermal Drug Delivery System Market Size by Country (2020-2025)

7.4 Europe Transdermal Drug Delivery System Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Transdermal Drug Delivery System Market Size (2020-2031)

8.2 Asia-Pacific Transdermal Drug Delivery System Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Transdermal Drug Delivery System Market Size by Region (2020-2025)

8.4 Asia-Pacific Transdermal Drug Delivery System Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Transdermal Drug Delivery System Market Size (2020-2031)

9.2 Latin America Transdermal Drug Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Transdermal Drug Delivery System Market Size by Country (2020-2025)

9.4 Latin America Transdermal Drug Delivery System Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Transdermal Drug Delivery System Market Size (2020-2031)

10.2 Middle East & Africa Transdermal Drug Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2020-2025)

10.4 Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Hisamitsu

11.1.1 Hisamitsu Company Details

11.1.2 Hisamitsu Business Overview

11.1.3 Hisamitsu Transdermal Drug Delivery System Introduction

11.1.4 Hisamitsu Revenue in Transdermal Drug Delivery System Business (2020-2025)

11.1.5 Hisamitsu Recent Development

11.2 Mylan

11.2.1 Mylan Company Details

11.2.2 Mylan Business Overview

11.2.3 Mylan Transdermal Drug Delivery System Introduction

11.2.4 Mylan Revenue in Transdermal Drug Delivery System Business (2020-2025)

11.2.5 Mylan Recent Development

11.3 GSK

11.3.1 GSK Company Details

11.3.2 GSK Business Overview

11.3.3 GSK Transdermal Drug Delivery System Introduction

11.3.4 GSK Revenue in Transdermal Drug Delivery System Business (2020-2025)

11.3.5 GSK Recent Development

11.4 Novartis

11.4.1 Novartis Company Details

11.4.2 Novartis Business Overview

11.4.3 Novartis Transdermal Drug Delivery System Introduction

11.4.4 Novartis Revenue in Transdermal Drug Delivery System Business (2020-2025)

11.4.5 Novartis Recent Development

11.5 Teve (Actavis)

11.5.1 Teve (Actavis) Company Details

11.5.2 Teve (Actavis) Business Overview

11.5.3 Teve (Actavis) Transdermal Drug Delivery System Introduction

11.5.4 Teve (Actavis) Revenue in Transdermal Drug Delivery System Business (2020-2025)

11.5.5 Teve (Actavis) Recent Development

11.6 Johnson & Johnson

11.6.1 Johnson & Johnson Company Details

11.6.2 Johnson & Johnson Business Overview

11.6.3 Johnson & Johnson Transdermal Drug Delivery System Introduction

11.6.4 Johnson & Johnson Revenue in Transdermal Drug Delivery System Business (2020-2025)

11.6.5 Johnson & Johnson Recent Development

11.7 Lohmann

11.7.1 Lohmann Company Details

11.7.2 Lohmann Business Overview

11.7.3 Lohmann Transdermal Drug Delivery System Introduction

11.7.4 Lohmann Revenue in Transdermal Drug Delivery System Business (2020-2025)

11.7.5 Lohmann Recent Development

11.8 Teikoku Seiyaku

11.8.1 Teikoku Seiyaku Company Details

11.8.2 Teikoku Seiyaku Business Overview

11.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Introduction

11.8.4 Teikoku Seiyaku Revenue in Transdermal Drug Delivery System Business (2020-2025)

11.8.5 Teikoku Seiyaku Recent Development

11.9 Bayer

11.9.1 Bayer Company Details

11.9.2 Bayer Business Overview

11.9.3 Bayer Transdermal Drug Delivery System Introduction

11.9.4 Bayer Revenue in Transdermal Drug Delivery System Business (2020-2025)

11.9.5 Bayer Recent Development

11.10 Lingrui

11.10.1 Lingrui Company Details

11.10.2 Lingrui Business Overview

11.10.3 Lingrui Transdermal Drug Delivery System Introduction

11.10.4 Lingrui Revenue in Transdermal Drug Delivery System Business (2020-2025)

11.10.5 Lingrui Recent Development

11.11 Sanofi

11.11.1 Sanofi Company Details

11.11.2 Sanofi Business Overview

11.11.3 Sanofi Transdermal Drug Delivery System Introduction

11.11.4 Sanofi Revenue in Transdermal Drug Delivery System Business (2020-2025)

11.11.5 Sanofi Recent Development

11.12 Qizheng

11.12.1 Qizheng Company Details

11.12.2 Qizheng Business Overview

11.12.3 Qizheng Transdermal Drug Delivery System Introduction

11.12.4 Qizheng Revenue in Transdermal Drug Delivery System Business (2020-2025)

11.12.5 Qizheng Recent Development

11.13 Endo

11.13.1 Endo Company Details

11.13.2 Endo Business Overview

11.13.3 Endo Transdermal Drug Delivery System Introduction

11.13.4 Endo Revenue in Transdermal Drug Delivery System Business (2020-2025)

11.13.5 Endo Recent Development

11.14 Huarun 999

11.14.1 Huarun 999 Company Details

11.14.2 Huarun 999 Business Overview

11.14.3 Huarun 999 Transdermal Drug Delivery System Introduction

11.14.4 Huarun 999 Revenue in Transdermal Drug Delivery System Business (2020-2025)

11.14.5 Huarun 999 Recent Development

11.15 Haw Par

11.15.1 Haw Par Company Details

11.15.2 Haw Par Business Overview

11.15.3 Haw Par Transdermal Drug Delivery System Introduction

11.15.4 Haw Par Revenue in Transdermal Drug Delivery System Business (2020-2025)

11.15.5 Haw Par Recent Development

11.16 Nichiban

11.16.1 Nichiban Company Details

11.16.2 Nichiban Business Overview

11.16.3 Nichiban Transdermal Drug Delivery System Introduction

11.16.4 Nichiban Revenue in Transdermal Drug Delivery System Business (2020-2025)

11.16.5 Nichiban Recent Development

11.17 Mentholatum

11.17.1 Mentholatum Company Details

11.17.2 Mentholatum Business Overview

11.17.3 Mentholatum Transdermal Drug Delivery System Introduction

11.17.4 Mentholatum Revenue in Transdermal Drug Delivery System Business (2020-2025)

11.17.5 Mentholatum Recent Development

11.18 Laboratoires Genevrier

11.18.1 Laboratoires Genevrier Company Details

11.18.2 Laboratoires Genevrier Business Overview

11.18.3 Laboratoires Genevrier Transdermal Drug Delivery System Introduction

11.18.4 Laboratoires Genevrier Revenue in Transdermal Drug Delivery System Business (2020-2025)

11.18.5 Laboratoires Genevrier Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Hisamitsu

Mylan NV

GSK

Novartis

Teve (Actavis)

Johnson & Johnson

Lohmann

TEIKOKU SEIYAKU

Bayer

Lingrui

Sanofi

Qizheng

Endo

Huarun 999

Haw Par

Nichiban

Mentholatum

Laboratoires Genevrier

List of Tables

Table 1. Global Transdermal Drug Delivery System Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Fentanyl

Table 3. Key Players of Nitroglycerin

Table 4. Key Players of Estradiol

Table 5. Key Players of Nicotine

Table 6. Key Players of Other

Table 7. Global Transdermal Drug Delivery System Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Transdermal Drug Delivery System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Transdermal Drug Delivery System Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Transdermal Drug Delivery System Market Share by Region (2020-2025)

Table 11. Global Transdermal Drug Delivery System Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Transdermal Drug Delivery System Market Share by Region (2026-2031)

Table 13. Transdermal Drug Delivery System Market Trends

Table 14. Transdermal Drug Delivery System Market Drivers

Table 15. Transdermal Drug Delivery System Market Challenges

Table 16. Transdermal Drug Delivery System Market Restraints

Table 17. Global Transdermal Drug Delivery System Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Transdermal Drug Delivery System Market Share by Players (2020-2025)

Table 19. Global Top Transdermal Drug Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Delivery System as of 2024)

Table 20. Ranking of Global Top Transdermal Drug Delivery System Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Transdermal Drug Delivery System Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Transdermal Drug Delivery System, Headquarters and Area Served

Table 23. Global Key Players of Transdermal Drug Delivery System, Product and Application

Table 24. Global Key Players of Transdermal Drug Delivery System, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Transdermal Drug Delivery System Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Transdermal Drug Delivery System Revenue Market Share by Type (2020-2025)

Table 28. Global Transdermal Drug Delivery System Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Transdermal Drug Delivery System Revenue Market Share by Type (2026-2031)

Table 30. Global Transdermal Drug Delivery System Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Transdermal Drug Delivery System Revenue Market Share by Application (2020-2025)

Table 32. Global Transdermal Drug Delivery System Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Transdermal Drug Delivery System Revenue Market Share by Application (2026-2031)

Table 34. North America Transdermal Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Transdermal Drug Delivery System Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Transdermal Drug Delivery System Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Transdermal Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Transdermal Drug Delivery System Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Transdermal Drug Delivery System Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Transdermal Drug Delivery System Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Transdermal Drug Delivery System Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Transdermal Drug Delivery System Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Transdermal Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Transdermal Drug Delivery System Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Transdermal Drug Delivery System Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Transdermal Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2026-2031) & (US$ Million)

Table 49. Hisamitsu Company Details

Table 50. Hisamitsu Business Overview

Table 51. Hisamitsu Transdermal Drug Delivery System Product

Table 52. Hisamitsu Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)

Table 53. Hisamitsu Recent Development

Table 54. Mylan Company Details

Table 55. Mylan Business Overview

Table 56. Mylan Transdermal Drug Delivery System Product

Table 57. Mylan Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)

Table 58. Mylan Recent Development

Table 59. GSK Company Details

Table 60. GSK Business Overview

Table 61. GSK Transdermal Drug Delivery System Product

Table 62. GSK Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)

Table 63. GSK Recent Development

Table 64. Novartis Company Details

Table 65. Novartis Business Overview

Table 66. Novartis Transdermal Drug Delivery System Product

Table 67. Novartis Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)

Table 68. Novartis Recent Development

Table 69. Teve (Actavis) Company Details

Table 70. Teve (Actavis) Business Overview

Table 71. Teve (Actavis) Transdermal Drug Delivery System Product

Table 72. Teve (Actavis) Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)

Table 73. Teve (Actavis) Recent Development

Table 74. Johnson & Johnson Company Details

Table 75. Johnson & Johnson Business Overview

Table 76. Johnson & Johnson Transdermal Drug Delivery System Product

Table 77. Johnson & Johnson Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)

Table 78. Johnson & Johnson Recent Development

Table 79. Lohmann Company Details

Table 80. Lohmann Business Overview

Table 81. Lohmann Transdermal Drug Delivery System Product

Table 82. Lohmann Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)

Table 83. Lohmann Recent Development

Table 84. Teikoku Seiyaku Company Details

Table 85. Teikoku Seiyaku Business Overview

Table 86. Teikoku Seiyaku Transdermal Drug Delivery System Product

Table 87. Teikoku Seiyaku Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)

Table 88. Teikoku Seiyaku Recent Development

Table 89. Bayer Company Details

Table 90. Bayer Business Overview

Table 91. Bayer Transdermal Drug Delivery System Product

Table 92. Bayer Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)

Table 93. Bayer Recent Development

Table 94. Lingrui Company Details

Table 95. Lingrui Business Overview

Table 96. Lingrui Transdermal Drug Delivery System Product

Table 97. Lingrui Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)

Table 98. Lingrui Recent Development

Table 99. Sanofi Company Details

Table 100. Sanofi Business Overview

Table 101. Sanofi Transdermal Drug Delivery System Product

Table 102. Sanofi Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)

Table 103. Sanofi Recent Development

Table 104. Qizheng Company Details

Table 105. Qizheng Business Overview

Table 106. Qizheng Transdermal Drug Delivery System Product

Table 107. Qizheng Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)

Table 108. Qizheng Recent Development

Table 109. Endo Company Details

Table 110. Endo Business Overview

Table 111. Endo Transdermal Drug Delivery System Product

Table 112. Endo Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)

Table 113. Endo Recent Development

Table 114. Huarun 999 Company Details

Table 115. Huarun 999 Business Overview

Table 116. Huarun 999 Transdermal Drug Delivery System Product

Table 117. Huarun 999 Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)

Table 118. Huarun 999 Recent Development

Table 119. Haw Par Company Details

Table 120. Haw Par Business Overview

Table 121. Haw Par Transdermal Drug Delivery System Product

Table 122. Haw Par Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)

Table 123. Haw Par Recent Development

Table 124. Nichiban Company Details

Table 125. Nichiban Business Overview

Table 126. Nichiban Transdermal Drug Delivery System Product

Table 127. Nichiban Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)

Table 128. Nichiban Recent Development

Table 129. Mentholatum Company Details

Table 130. Mentholatum Business Overview

Table 131. Mentholatum Transdermal Drug Delivery System Product

Table 132. Mentholatum Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)

Table 133. Mentholatum Recent Development

Table 134. Laboratoires Genevrier Company Details

Table 135. Laboratoires Genevrier Business Overview

Table 136. Laboratoires Genevrier Transdermal Drug Delivery System Product

Table 137. Laboratoires Genevrier Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)

Table 138. Laboratoires Genevrier Recent Development

Table 139. Research Programs/Design for This Report

Table 140. Key Data Information from Secondary Sources

Table 141. Key Data Information from Primary Sources

Table 142. Authors List of This Report

List of Figures

Figure 1. Transdermal Drug Delivery System Picture

Figure 2. Global Transdermal Drug Delivery System Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Transdermal Drug Delivery System Market Share by Type: 2024 VS 2031

Figure 4. Fentanyl Features

Figure 5. Nitroglycerin Features

Figure 6. Estradiol Features

Figure 7. Nicotine Features

Figure 8. Other Features

Figure 9. Global Transdermal Drug Delivery System Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Transdermal Drug Delivery System Market Share by Application: 2024 VS 2031

Figure 11. OTC Case Studies

Figure 12. Rx Case Studies

Figure 13. Transdermal Drug Delivery System Report Years Considered

Figure 14. Global Transdermal Drug Delivery System Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Transdermal Drug Delivery System Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Transdermal Drug Delivery System Market Share by Region: 2024 VS 2031

Figure 17. Global Transdermal Drug Delivery System Market Share by Players in 2024

Figure 18. Global Top Transdermal Drug Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Delivery System as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Transdermal Drug Delivery System Revenue in 2024

Figure 20. North America Transdermal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Transdermal Drug Delivery System Market Share by Country (2020-2031)

Figure 22. United States Transdermal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Transdermal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Transdermal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Transdermal Drug Delivery System Market Share by Country (2020-2031)

Figure 26. Germany Transdermal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Transdermal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Transdermal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Transdermal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Transdermal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Transdermal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Transdermal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Transdermal Drug Delivery System Market Share by Region (2020-2031)

Figure 34. China Transdermal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Transdermal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Transdermal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Transdermal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Transdermal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Transdermal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Transdermal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Transdermal Drug Delivery System Market Share by Country (2020-2031)

Figure 42. Mexico Transdermal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Transdermal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Transdermal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Transdermal Drug Delivery System Market Share by Country (2020-2031)

Figure 46. Turkey Transdermal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Transdermal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Transdermal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Hisamitsu Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)

Figure 50. Mylan Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)

Figure 51. GSK Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)

Figure 52. Novartis Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)

Figure 53. Teve (Actavis) Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)

Figure 54. Johnson & Johnson Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)

Figure 55. Lohmann Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)

Figure 56. Teikoku Seiyaku Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)

Figure 57. Bayer Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)

Figure 58. Lingrui Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)

Figure 59. Sanofi Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)

Figure 60. Qizheng Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)

Figure 61. Endo Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)

Figure 62. Huarun 999 Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)

Figure 63. Haw Par Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)

Figure 64. Nichiban Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)

Figure 65. Mentholatum Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)

Figure 66. Laboratoires Genevrier Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Transdermal Adhesive Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pain Relief Patches Market Research Report 2025

Pain Relieving Patches Market

Transdermal Medical Patch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Topical Pain Relief Patch Market Research Report 2024

Global Transdermal Transmucosal Drug Delivery System Market Insights Forecast to 2030

Global Microneedle Patch Transdermal Drug Delivery Systems Market Research Report 2025

Transdermal Therapeutic Systems TTS Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Transdermal Adhesives Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Transdermal Gel Market Research Report 2024

Global Microarray Patch Transdermal Drug Delivery Systems Market Research Report 2025

Global Adhesive Solutions for Drug Delivery Polymer Market Research Report 2024

Transdermal Drug Delivery Patches Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Transdermal Patch for Pain Relief Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Medical Transdermal Patch Market Research Report 2025

Global Transdermal Patch Testing System Market Research Report 2024

Transdermal Drug Delivery Formulation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Transdermal and Transmucosal Drug Delivery Market Research Report 2024

Global Targeted Drug Delivery System Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions